STING pathway investigation


Cisbio releases a new HTRF assay offer dedicated to the cGas/STING pathway.

Cisbio announces the launch of 3 novel HTRF STING assays

Cisbio extends its assay portfolio for immuno-oncology drug discovery with breakthrough biochemical and cell-based STING assays.

Get the press release

New STING HTRF-based offer

3 novel HTRF STING assays have been developed to identify and characterize compounds targeting the STING protein. These new assays come in addition to three important assays released last year: TBK1, IRF3 and IFN-beta.